| Kollmeier MA, Zelefsky MJ
What is the role of androgen deprivation therapy in the treatment of locally advanced prostate cancer? [JOURNAL ARTICLE]
Nat Clin Pract Urol 2008 Sep 23.
Abstract | Full Citation | | Smith MR, Bae K, Efstathiou JA, et al.
Diabetes and mortality in men with locally advanced prostate cancer: RTOG 92-02. [Journal Article, Randomized Controlled Trial, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't]
J Clin Oncol 2008 Sep 10; 26(26):4333-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Gnant M, Mlineritsch B, Luschin-Ebengreuth G, et al.
Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy. [JOURNAL ARTICLE]
Lancet Oncol 2008 Aug 19.
Abstract | Full Citation | | Gulley JL, Aragon-Ching JB, Steinberg SM, et al.
Kinetics of serum androgen normalization and factors associated with testosterone reserve after limited androgen deprivation therapy for nonmetastatic prostate cancer. [Journal Article, Research Support, N.I.H., Extramural, Research Support, N.I.H., Intramural]
J Urol 2008 Oct; 180(4):1432-7; discussion 1437.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Crook J, Ludgate C, Malone S, et al.
Final Report of Multicenter Canadian Phase III Randomized Trial of 3 Versus 8 Months of Neoadjuvant Androgen Deprivation Therapy Before Conventional-Dose Radiotherapy for Clinically Localized Prostate Cancer. [JOURNAL ARTICLE]
Int J Radiat Oncol Biol Phys 2008 Aug 14.
Abstract | Full Citation | Find Related Articles | | Soga N, Arima K, Sugimura Y
Undetectable Level of Prostate Specific Antigen (PSA) Nadir Predicts PSA Biochemical Failure in Local Prostate Cancer with Delayed-combined Androgen Blockade. [JOURNAL ARTICLE]
Jpn J Clin Oncol 2008 Aug 12.
Abstract | Full Citation | | Namiki S, Ishidoya S, Saito S, et al.
[Quality of life following endocrine therapy for advanced prostate cancer: a comparative study between LH-RH agonist 1-month depot and 3-month depot] [English Abstract, Journal Article]
Nippon Hinyokika Gakkai Zasshi 2008 Jul; 99(5):631-7.
Abstract | Full Citation | | van Bon AC, Wiersinga WM
Goserelin-induced transient thyrotoxicosis in a hypothyroid woman on L-thyroxine replacement. [Journal Article]
Neth J Med 2008 Jun; 66(6):256-8.
Abstract | Full Citation | | Huang ST, Hsieh ML
Evaluation of resistance index in patients with prostate cancer. [Journal Article]
Anticancer Res 2008 Jul-Aug; 28(4A):1985-8.
Abstract | Full Citation | | Moretti RM, Montagnani Marelli M, Mai S, et al.
Gonadotropin-releasing hormone agonists suppress melanoma cell motility and invasiveness through the inhibition of alpha3 integrin and MMP-2 expression and activity. [Journal Article]
Int J Oncol 2008 Aug; 33(2):405-13.
Abstract | Full Citation |   |
|
| |
Advertise on this site.
|
